Inventor · disambiguated record
Hong Wu
Also filed as: WU HONG · WU HONG-PING
31 granted patents·8 pending applications·194 citations·filing 1990–2024
95Inventor score
Files withBRISTOL MYERS SQUIBB CO17HUAWEI TECH CO LTD4HEFEI INST PHYSICAL SCI CAS3PRECEDO PHARMACEUTICALS CO LTD3WROBLESKI STEPHEN T3
Top patents by PatentIndex Score
39 records- 0192US7323482B2Thiazolyl-based compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jan 29, 2008·12 cites·11 claims
- 0292US6653304B2Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseasesBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Nov 25, 2003·62 cites·8 claims
- 0390US9814709B2Bruton's tyrosine kinase inhibitorHEFEI INST PHYSICAL SCI CAS·Filed 2015·Granted Nov 14, 2017·16 cites·13 claims
- 0488US10294229B2Heteroaryl substituted aminopyridine compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted May 21, 2019·9 cites·13 claims
- 0583US7169771B2Thiazolyl-based compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jan 30, 2007·11 cites·2 claims
- 0681US9657009B2Heteroaryl substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted May 23, 2017·4 cites·11 claims
- 0781US9169252B2Heteroaryl substituted nicotinamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 27, 2015·5 cites·9 claims
- 0880US9546153B2Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 17, 2017·5 cites·9 claims
- 0980US5156004AComposite semiconductive thermoelectric refrigerating deviceWU HONG PING·Filed 1990·Granted Oct 20, 1992·56 cites·32 claims
- 1078US10202390B2Heteroaryl substituted aminopyridine compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Feb 12, 2019·3 cites·12 claims
- 1177US8338604B2Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitorsHYNES JOHN·Filed 2009·Granted Dec 25, 2012·4 cites·8 claims
- 1276US7642257B2Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jan 5, 2010·2 cites·13 claims
- 1370US8987268B2Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseasesWROBLESKI STEPHEN T·Filed 2012·Granted Mar 24, 2015·2 cites·14 claims
- 1466US7419978B2Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Sep 2, 2008·2 cites·10 claims
- 1565US2025145665A1Macrocyclic peptides useful as modulators of tnf alphaBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1664US9221826B2Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseasesWROBLESKI STEPHEN T·Filed 2012·Granted Dec 29, 2015·1 cites·10 claims
- 1762US9802902B2Antifungal compoundAGENCY SCIENCE TECH & RES·Filed 2016·Granted Oct 31, 2017·0 cites·2 claims
- 1861US9493424B2Antifungal compoundAGENCY SCIENCE TECH & RES·Filed 2013·Granted Nov 15, 2016·0 cites·14 claims
- 1958US10544133B2Heteroaryl substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jan 28, 2020·0 cites·9 claims
- 2057US12204566B2Aggregating mapping tile dataDEERE & CO·Filed 2022·Granted Jan 21, 2025·0 cites·20 claims
- 2155US12304916B2Thienopyridinyl and thiazolopyridinyl compounds useful as IRAK4 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted May 20, 2025·0 cites·7 claims
- 2254US12001512B2Generating labeled synthetic training dataMINERAL EARTH SCIENCES LLC·Filed 2021·Granted Jun 4, 2024·0 cites·20 claims
- 2354US10023562B2Heteroaryl substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jul 17, 2018·0 cites·11 claims
- 2454US2025097139A1Packet sending method, network device, and systemHUAWEI TECH CO LTD·Filed 2024·Application pending·0 cites
- 2552US2024340239A1Route advertisement method and related deviceHUAWEI TECH CO LTD·Filed 2024·Application pending·0 cites
- 2652US2024018129A1Compounds as pu. 1 inhibitorsUNIV BEIJING·Filed 2021·Application pending·0 cites
- 2750US12304914B2Pyrazolo[3,4-d]pyrrolo[1,2-b]pyridazinyl compounds useful as IRAK4 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted May 20, 2025·0 cites·8 claims
- 2849US2013178444A1Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activityBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 2948US2006064768A1Murine Pten null prostate cancer modelUNIV CALIFORNIA·Filed 2004·Application pending·0 cites
- 3048US2022337508A1Path Verification Method and Related DeviceHUAWEI TECH CO LTD·Filed 2022·Application pending·0 cites
- 3147US8410139B2Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activityHYNES JOHN·Filed 2010·Granted Apr 2, 2013·0 cites·4 claims
- 3246US2022417153A1Route attribute update method, network device, and systemHUAWEI TECH CO LTD·Filed 2022·Application pending·0 cites
- 3343US10781214B2Kinase inhibitor against wild-type and mutant EGFRPRECEDO PHARMACEUTICALS CO LTD·Filed 2016·Granted Sep 22, 2020·0 cites·11 claims
- 3440US10669238B2Irreversible bruton's tyrosine kinase inhibitorHEFEI INST PHYSICAL SCI CAS·Filed 2016·Granted Jun 2, 2020·0 cites·21 claims
- 3538US8921368B2Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseasesWROBLESKI STEPHEN T·Filed 2012·Granted Dec 30, 2014·0 cites·9 claims
- 3636US10975082B2Inhibitor of FLT3 kinase and use thereofPRECEDO PHARMACEUTICALS CO LTD·Filed 2017·Granted Apr 13, 2021·0 cites·14 claims
- 3736US10350210B2EGFR and ALK dual inhibitorPRECEDO PHARMACEUTICALS CO LTD·Filed 2016·Granted Jul 16, 2019·0 cites·18 claims
- 3835US10618903B2Heteroaryl substituted aminopyridine compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 14, 2020·0 cites·10 claims
- 3933US10266535B2Inhibitor of FLT3 kinase and use thereofHEFEI INST PHYSICAL SCI CAS·Filed 2015·Granted Apr 23, 2019·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Hong Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →